- Home
- ATR vs QGEN Comparison
ATR vs QGEN Comparison
Compare ATR & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATR
- QGEN
- Stock Information
- Founded
- ATR 1992
- QGEN 1986
- Country
- ATR United States
- QGEN Netherlands
- Employees
- ATR N/A
- QGEN N/A
- Industry
- ATR Plastic Products
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATR Industrials
- QGEN Health Care
- Exchange
- ATR Nasdaq
- QGEN Nasdaq
- Market Cap
- ATR 9.3B
- QGEN 10.3B
- IPO Year
- ATR 1993
- QGEN 1996
- Fundamental
- Price
- ATR $138.54
- QGEN $47.56
- Analyst Decision
- ATR Strong Buy
- QGEN Buy
- Analyst Count
- ATR 5
- QGEN 8
- Target Price
- ATR $184.00
- QGEN $51.01
- AVG Volume (30 Days)
- ATR 445.1K
- QGEN 1.4M
- Earning Date
- ATR 10-23-2025
- QGEN 11-05-2025
- Dividend Yield
- ATR 1.30%
- QGEN 3.18%
- EPS Growth
- ATR 21.86
- QGEN 405.09
- EPS
- ATR 5.79
- QGEN 1.69
- Revenue
- ATR $3,610,693,000.00
- QGEN $2,040,067,000.00
- Revenue This Year
- ATR $4.33
- QGEN $7.22
- Revenue Next Year
- ATR $5.08
- QGEN $5.66
- P/E Ratio
- ATR $23.92
- QGEN $27.78
- Revenue Growth
- ATR 1.51
- QGEN 5.15
- 52 Week Low
- ATR $130.85
- QGEN $37.63
- 52 Week High
- ATR $178.03
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- ATR 40.89
- QGEN 45.68
- Support Level
- ATR $134.44
- QGEN $46.27
- Resistance Level
- ATR $140.57
- QGEN $47.38
- Average True Range (ATR)
- ATR 2.25
- QGEN 0.71
- MACD
- ATR 0.39
- QGEN -0.20
- Stochastic Oscillator
- ATR 46.12
- QGEN 42.05
About ATR AptarGroup Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).